Keyphrases
Chronic Kidney Disease
96%
COVID-19
50%
Chronic Kidney Disease Patients
43%
Hemodialysis
42%
Risk Factors
40%
Acute Kidney Injury
40%
Hemodialysis Patients
40%
Systematic Meta-analysis
37%
Meta-analysis
37%
Nephrotic Syndrome
37%
Non-tunneled Hemodialysis Catheter
37%
Type 1 Diabetes Mellitus (T1DM)
37%
Surabaya
35%
Nephrology
31%
Indonesia
27%
Hypertension
25%
Double-lumen Catheter
24%
Hyperkalemia
24%
Mellitus Diabetes
23%
Proteinuria
23%
Kidney Transplantation
23%
Infected Patients
22%
Mesenchymal Stem Cells
22%
Immunosuppressive Agents
22%
Patency
22%
General Hospital
21%
Adult Patients
21%
Non-associated
20%
Reticulocyte Hemoglobin Equivalent (RET-He)
18%
Central Venous Catheter
18%
Stem Cell Aging
18%
Stem Cell Osteogenesis
18%
Catheter Tip
18%
Minimal Change Disease
18%
Internist
18%
Duration of Therapy
18%
Kidney Transplant Recipients
18%
Clinical Characteristics
18%
Dietary Management
18%
Complication Management
18%
Focal Segmental Glomerulosclerosis
18%
Multiple Complications
18%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
18%
Malnourishment
18%
Leukemia Patients
18%
Management Challenges
18%
Estimated Glomerular Filtration Rate
18%
Hepatitis B Virus Infection
18%
C-reactive Protein
18%
Chronic Kidney Disease Stage
18%
Medicine and Dentistry
Chronic Kidney Disease
99%
Hemodialysis
61%
COVID-19
37%
Nephrotic Syndrome
37%
Dialysis Catheter
37%
Diabetes Mellitus
37%
Mesenchymal Stem Cell
29%
Kidney Transplantation
27%
Renal Biopsy
24%
Hyperkalemia
24%
Infection
24%
Nephrology
24%
Immunosuppressive Drug
19%
N(g),n(g) Dimethylarginine
18%
Reticulocyte
18%
Central Venous Catheter
18%
Bone Development
18%
Osteoblastogenesis
18%
Adipose-Derived Mesenchymal Stem Cell
18%
Focal Segmental Glomerulosclerosis
18%
Minimal Change Disease
18%
Kidney Graft
18%
Hydroxychloroquine
18%
Lopinavir/Ritonavir
18%
C Reactive Protein
18%
Polycystic Kidney Disease
18%
Meta-Analysis
18%
Systematic Review
18%
Acute Kidney Injury
18%
Deep Vein Thrombosis
18%
Hypochromic Anemia
18%
Dexamethasone
18%
Cation Exchange Resin
18%
Cellular Senescence
18%
Lupus Nephritis
18%
Glomerulus
14%
Anemia
12%
Antithrombotic
11%
Thrombosis
9%
Superior Vena Cava
9%
Right Atrium
9%
Inferior Vena Cava
9%
Steroid Therapy
9%
Polystyrenesulfonate Calcium
9%
Patiromer
9%
Erythrocyte
9%
Proteinuria
8%
Physical Examination
8%
Leukocytosis
8%
Creatinine
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Chronic Kidney Failure
86%
Diseases
58%
Nephrotic Syndrome
37%
Coronavirinae
37%
Acute Kidney Failure
37%
Diabetes Mellitus
37%
Infection
30%
Proteinuria
25%
Hyperkalemia
24%
Iron Deficiency Anemia
18%
Deep Vein Thrombosis
18%
C Reactive Protein
18%
Kidney Disease
18%
Focal Glomerulosclerosis
18%
Candesartan
18%
Prevalence
18%
Dexamethasone
18%
Immunosuppressive Agent
18%
Hepatitis B
18%
Hepatitis C
18%
Hydroxychloroquine
18%
Lopinavir Plus Ritonavir
18%
Imatinib
18%
Chronic Myeloid Leukemia
18%
Cation Exchange Resin
18%
Inflammation
15%
Hepatitis C Virus
14%
D Dimer
12%
Creatinine
12%
Hepatitis B Virus
11%
Anemia
9%
Hepatitis B Antigen
9%
Patiromer
9%
Polystyrenesulfonate Calcium
9%
Anticoagulant Agent
9%
Remission
8%
Hypoalbuminemia
7%
Comorbidity
7%
Warfarin
6%
Fondaparinux
6%
Hemoglobins
6%
Ureaplasma
6%
Graft Rejection
6%
Leukocytosis
6%
Sodium Zirconium Cyclosilicate
6%
Isotopes of Potassium
6%
Thrombosis
5%
Bone Morphogenetic Protein 2
5%
Fibrinogen
5%